Content about Bone density

October 11, 2012
Mission Pharmacal launches Binosto for osteoporosis

Mission Pharmacal has launched what it called an alternative to pill therapy for osteoporosis.

SAN ANTONIO — Mission Pharmacal has launched what it called an alternative to pill therapy for osteoporosis.

The drug maker announced Thursday the availability of Binosto (alendronate sodium) effervescent tablets for buffered oral solution in pharmacies. The drug is used to treat osteoporosis in postmenopausal women and increase bone mass in men with the condition.

September 21, 2012
Amgen drug approved for osteoporosis in men

The Food and Drug Administration has approved a new usage for an Amgen drug, the drug maker said.

THOUSAND OAKS, Calif. — The Food and Drug Administration has approved a new usage for an Amgen drug, the drug maker said.

The biotech manufacturer announced the FDA approval of Prolia (denosumab) to increase bone mass in men with osteoporosis who are at high risk for fracture. The drug already was approved for osteoporosis in postmenopausal women.

August 7, 2012
Lilly announces osteoporosis drug study results

A biotech drug made by Eli Lilly for osteoporosis appeared no more or less effective than a pharmaceutical drug available as a generic in treating women with related bone fractures, but was more effective in some other measures, according to results of a late-stage clinical trial released Tuesday.

INDIANAPOLIS — A biotech drug made by Eli Lilly for osteoporosis appeared no more or less effective than a pharmaceutical drug available as a generic in treating women with related bone fractures, but was more effective in some other measures, according to results of a late-stage clinical trial released Tuesday.

June 1, 2010
FDA approves Amgen's Prolia

The Food and Drug Administration has approved a new drug from Amgen for osteoporosis, Amgen...